AbCellera today announced the appointment of Victor Sandor, M.D.C.M, to its Board of Directors as an independent director. "Dr. Sandor is an experienced director and a distinguished medical oncologist ...

Growing support for perioperative vs neoadjuvant therapy, but many questions yet to be ans ...

The shape of that competition is given physical form at the 2026 BIO International Convention (BIO 2026) in San Diego, ...

Now, Quantum BioPharma Ltd. is challenging that reality. The company is advancing Lucid-MS, a patented, first-in-class drug candidate that takes a fundamentally different approach by directly ...

NetworkNewsAudio announces the Audio Press Release (APR) titled “Novel Patented Myelin Drug-Discovery Strategy Targets Massive Unmet Need in Multiple Sclerosis,” featuring Quantum BioPharma Ltd.

Brian Hilberdink, president of U.S. Human Pharma, Boehringer Ingelheim, explains why shifting the conversation from simple ...

Merck & Co. will partner with Protillion Biosciences to discover multiple new therapy candidates, through a collaboration ...

The physical AI platform, named AI Experimentalist, translates research goals from natural language into experiments at scale.

Century Health, a pioneer in applying AI to real-world clinical data to accelerate research, and Arizona Gastrointestinal Associates (AGA), an independent, physician-led gastroenterology network, ...

Quantum Cyber N.V. (Nasdaq:QUCY) is building a vertically integrated autonomous defense platform around top-tier Ukraine-tested combat drones now heading into U.S. production, a ...

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) today announces its placement in an editorial published by BioMedWire (BMW), one ...

BioMedWire Editorial Coverage: Multiple sclerosis (“MS”) robs people of control over their own bodies — slowly, relentlessly and without a cure. More ...